It was reported on Dec, 6 by Barchart.com. (NasdaqGS:MDLZ), gives us a value of 0.910000. Mondelez International, Inc. (NASDAQ:MDLZ) has risen 5.69% since December 7, 2016 and is uptrending. Therefore 26% are positive. Royal Bank Of Canada restated a "buy" rating and issued a $53.00 price objective on shares of Mondelez International in a research report on Tuesday, October 3rd. As per Friday, October 13, the company rating was maintained by UBS. Simmons Bank boosted its position in Mondelez International by 0.3% in the 1st quarter. (NASDAQ:TRVN) rating on Monday, January 9. Stifel Nicolaus has "Hold" rating and $4500 target. It shows the cash a company is able to generate after spending the money need to maintain or grow its asset base. The company had revenue of $6.53 billion during the quarter, compared to the consensus estimate of $6.45 billion. The stock of Helmerich & Payne, Inc. (NASDAQ:MDLZ) has "Overweight" rating given on Wednesday, November 1 by JP Morgan. On Friday, July 31 the stock rating was maintained by RBC Capital Markets with "Outperform".
Brokerage houses, on average, are recommending investors to buy Activision Blizzard, Inc. "I think the market moves a little bit on that, but mostly moves on fundamentals and sentiment, which are strong", said Sean O'Hara, director at Pacer Financial Inc. (NASDAQ:MDLZ) earned "Overweight" rating by PiperJaffray on Tuesday, July 25. Considering that the stock daily volume of 8.19 million shares, this represents a pretty noteworthy trading in volume size. MDLZ's profit will be $836.85M for 19.38 P/E if the $0.56 EPS becomes a reality. Yhb Invest Advsr Inc stated it has 0.73% of its portfolio in Mondelez International, Inc. Mondelez International, Inc.'s beta is 1.00 whilst the stock has an average true range (ATR) of 0.70. Therefore 76% are positive. Mondelez International's quarterly revenue was up 2.1% on a year-over-year basis. analysts forecast that Mondelez International, Inc. will post 2.14 earnings per share for the current fiscal year. The firm has "Outperform" rating by RBC Capital Markets given on Thursday, April 28.
The outstanding shares for Mondelez International, Inc.is 1494.39 with a shares float of 1484.4. About 8.19M shares traded or 0.09% up from the average. For example, a company with 40 million shares selling at $100 a share would have a market cap of $4 billion. The rating was maintained by Stifel Nicolaus with "Hold" on Monday, September 18. When investing in a volatile security, the risk of success is increased just as much as the risk of failure. Its up 0.09, from 0.9 in 2017Q1. Credit Suisse Group increased their price target on shares of Mondelez International from $46.00 to $48.00 and gave the company an "outperform" rating in a report on Tuesday, October 31st.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Front Barnett Associates Limited Liability Corporation owns 0.07% invested in Mondelez International, Inc. (NASDAQ:MDLZ). Rampart Invest Mgmt Limited invested in 0.31% or 19,921 shares. 683 Capital Management Llc who had been investing in Mondelez Intl Inc (Put) for a number of months, seems to be bullish on the $64.75B market cap company. (NASDAQ:MDLZ). Central Bancshares Trust Communication accumulated 849 shares. Baldwin Brothers Ma invested 0.01% of its portfolio in Mondelez International, Inc. Eaton Vance Management now owns 5,038,277 shares of the company's stock valued at $217,603,000 after buying an additional 2,502,668 shares during the period. Linscomb & Williams Inc. now owns 13,433 shares of the company's stock valued at $580,000 after acquiring an additional 39 shares during the last quarter.
Analysts await Mondelez International, Inc. The NASDAQ-listed company saw a recent bid of $189.26 on volume of 11.58 million shares. Panagora Asset Inc reported 693,031 shares. First City Capital Mngmt holds 1.08% or 34,424 shares. However, the company's most recent quarter increase of 3.2% looks unattractive. Beese Fulmer Inv Mngmt owns 22,337 shares for 0.23% of their portfolio. Susquehanna initiated Mondelez International, Inc.
Mondelez International, Inc is a snack company.
Trevena, Inc., a biopharmaceutical company, develops various therapies based on breakthrough science to benefit patients and healthcare providers confronting serious medical conditions. The Company's product candidates include oliceridine injection, a Âµ-receptor G protein pathway selective modulator, which is in Phase III clinical trials for the management of moderate-to-severe acute pain where intravenous administration is preferred; TRV250, a G protein biased ligand targeting the d-receptor, which is in preclinical development for the treatment of migraine; and TRV734, a small molecule G protein biased ligand at the mu-receptor that is in Phase I clinical trials for the treatment of moderate to severe acute and chronic pain, as well as TRV027 for the treatment of acute heart failure. Zacks Price Response Indicator shows what a stock price could do after an earnings report. About 250,686 shares traded.
Mondelez International Company Profile Mondelez International, Inc is a snack company. It has underperformed by 69.23% the S&P500.
- LaVar Ball Gives Joel Embiid Advice Following 76ers Loss to Lakers
- Most Active Stock: Bank of America Corporation (BAC)
- Convention: Elect vibrant, young leaders - PDP South Africa
- NHL Agrees to Consider Seattle Expansion Proposal
- Death Stranding Still Teases Surrealism In New Trailer
- Senior Palestinian Official: Vice President Pence Not Welcome In Palestine
- Chipotle Mexican Grill (CMG) Stock Rating Reaffirmed by Credit Suisse Group
- UFC champ Georges St-Pierre vacates middleweight title, Whittaker-Rockhold set
- 'Zombiefied' Angelina Jolie lookalike reveals she's a total fraud
- Can Sage Therapeutics, Inc. (SAGE)'s Tomorrow Be Different? The Stock Increases Again